Intracavernosal versus intraurethral alprostadil: a prospective randomized study
Open Access
- 1 May 1999
- journal article
- clinical trial
- Published by Wiley in BJU International
- Vol. 83 (7), 812-815
- https://doi.org/10.1046/j.1464-410x.1999.00021.x
Abstract
Objective To compare the medicated urethral system for erection (MUSE) with standard intracavernosal prostaglandin E1 (PGE1) in the treatment of erectile dysfunction. Patients and methods Sixty co...Keywords
This publication has 16 references indexed in Scilit:
- Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunctionBritish Journal of Urology, 1998
- Priapism after transurethral alprostadilBritish Journal of Urology, 1998
- Muse therapy: preliminary clinical observationsUrology, 1997
- Predictors of Success and Risk Factors for Attrition in the Use of Intracavernous InjectionJournal of Urology, 1997
- Treatment of Men with Erectile Dysfunction with Transurethral AlprostadilNew England Journal of Medicine, 1997
- A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadilUrology, 1996
- High attrition rate with intracavernousinjection of prostaglandin E1 for impotencyUrology, 1994
- Intracavernous Injection of Prostaglandin E1 for the Treatment of Erectile ImpotenceJournal of Urology, 1989
- Efficiency and Side Effects of Prostaglandin El in the Treatment of Erectile DysfunctionJournal of Urology, 1988
- INTRACAVERNOUS INJECTION OF PAPAVERINE FOR ERECTILE FAILUREThe Lancet, 1982